doi: 10.3389/fnut.2025.1676080 Received 01 August 2025 Accepted 10 September 2025 Published 04 December 2025 Volume 12 - 2025 Edited by Lidia Daimiel, IMDEA Food Institute, Spain Reviewed by Juan Gerardo Reyes-Garca, Escuela Superior de Medicina (IPN), Mexico Sergio Adrin Terrasa, Italian Hospital of Buenos Aires, Argentina Updates Copyright 2025 Wirnitzer, Motevalli, Tanous, Drenowatz, Moser, Cramer, Rosemann, Wagner, Michalsen, Knechtle, Fras, Ritskes-Hoitinga, Marques, Mis, Stanford, Schubert, Goswami, Leitzmann, Fredriksen, Ruedl, Wilflingseder, Lima, Kessler, Jeitler, Khan, Joulaei, Fatemi, Knight, Kratky, Palmer, Haditsch, Jakse, Kofler, Pfeiffer, Cordova-Pozo, Tortella, Straub, Lynch, Schtzer, Krishnan, Fathima A., Gatterer, Kriwan, Abhishek, Nandgaonkar, Nandgaonkar, Adedara, Haro, Gericke, Neumann, Akhtar, Rashidlamir, Thangavelu, Ngoumou, Perpk, Klaper, Bhattacharya, Kirschner, Bessems, Jones, Peoples, Bescos, Duftner and Seifert
Anything that puts extra pressure on your median nerve can cause CTS
E.HodsonD
Faster-acting drugs have a higher abuse potential, DiFeliceantonio said
However, future retatrutide trials of longer duration and greater sample sizes may show even greater weight loss effectiveness compared to tirzepatide
